1-[2-[3-(4-ethylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(2-morpholin-4-ylethoxy)indole-3-carboxamide
C31H37FN8O3 — CID 139391240
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-[3-(4-ethylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(2-morpholin-4-ylethoxy)indole-3-carboxamide
1-[2-[3-(4-ethylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(2-morpholin-4-ylethoxy)indole-3-carboxamide (PubChem CID 139391240) has the molecular formula C31H37FN8O3 and a molecular weight of 588.69 g/mol. Its IUPAC name is 1-[2-[3-(4-ethylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(2-morpholin-4-ylethoxy)indole-3-carboxamide.
Molecular Properties
| Compound Name | 1-[2-[3-(4-ethylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(2-morpholin-4-ylethoxy)indole-3-carboxamide |
|---|---|
| PubChem CID | 139391240 |
| Molecular Formula | C31H37FN8O3 |
| Molecular Weight | 588.69 g/mol |
| Exact Mass | 588.30 |
| IUPAC Name | 1-[2-[3-(4-ethylpiperazin-1-yl)anilino]-5-fluoropyrimidin-4-yl]-5-(2-morpholin-4-ylethoxy)indole-3-carboxamide |
| SMILES | CCN1CCN(c2cccc(Nc3ncc(F)c(-n4cc(C(N)=O)c5cc(OCCN6CCOCC6)ccc54)n3)c2)CC1 |
| InChI | InChI=1S/C31H37FN8O3/c1-2-37-8-10-39(11-9-37)23-5-3-4-22(18-23)35-31-34-20-27(32)30(36-31)40-21-26(29(33)41)25-19-24(6-7-28(25)40)43-17-14-38-12-15-42-16-13-38/h3-7,18-21H,2,8-17H2,1H3,(H2,33,41)(H,34,35,36) |
| InChIKey | YZWYLTGUPOMNJP-UHFFFAOYSA-N |
| XLogP | 3.26 |
| TPSA | 114.01 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 588.69 |
| LogP ≤ 5 | 3.26 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139391240 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.